Skip to main content
. 2017 Sep 21;8(49):86312–86324. doi: 10.18632/oncotarget.21146

Figure 6. Schematic of MYCN-amplified SCLC before and after treatment with JQ1/ABT-263 combination.

Figure 6

In MYCN-amplified SCLC, N-Myc inhibits Bim. JQ1 treatment decreases N-Myc to up-regulate Bim. Combination of JQ1 with ABT-263 disrupts Bim’s interaction with BCL-2 and Mcl-1, leading to the liberation of Bim and apoptosis.